TenderlineUK
Procurement Intelligence
Search
Find a TenderAwardedContract details notice
Published 1 May 2025, 16:18 BST

Official UK procurement notice

NHS National Framework for Transition products (Axitinib and Eltrombopag)

Official notice

Authority: NHS England (Central government)

Open framework schemeGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)East Midlands (UKF)
+4 moreWest Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Framework ceiling (notional)£80,909,200framework ceiling, not attributable revenue · 1 value update
Submissions closed 4 Jul 2025awarded 16 Jul 2025
Awarded to Dr Reddy's Laboratories (UK) Ltd +6 more
Framework period 1 yr 4 moends 31 Jan 2027 · up to 31 Jan 2029 with extensions · starts 1 Oct 2025

Re-procurement openNHS National Framework for Lenvatinib · bids close

What is being bought

Published requirement description

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025

Offer reference number: CM/TNS/25/5722

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months.

Potential periods of call-offs under the framework agreement:

CM/TNS/25/5722/01 Axitinib and Eltrombopag

Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months)

Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months)

Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months)

Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Closed framework · open framework scheme (admission reopens)
Call-offs
every call-off is a further competition among the appointed suppliers
Bids received
15 bids received · 7 suppliers appointed
Framework period
1 yr 4 mo · up to 3 yrs 4 mo from 1 Oct 2025
Scheme runs until
31 Jan 2029
Buyer regions
UKC, UKD, UKF, UKG, UKH, UKJ, UKK
Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

Call-offs published through it1

Notices that name this framework as their framework in the official record. Many call-offs are never published, so this is a floor, not utilisation.

The lotProcurement structure

single lot · value published
Lot #1AwardedRenewal 1 yr 4 moSMEPublished value£80,909,200
Contract period: 1 Oct 2025 – 31 Jan 2027 (1 yr 4 mo) · up to 31 Jan 2029 with extensionsValue: £80,909,200 exc. VAT · £97,090,800 inc. VAT
Delivery: North East, North West, East Midlands, West Midlands, East of England, South East, South WestEligibility: SME eligible
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Price: 100%
Published sub-criteria (1)
  • Price is not the only award criterion: 100%
Published award criteria (1)
  • Price is not the only award criterion
What this means for your bid
  • Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NHS National Framework for Transition products (Axitinib and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Open framework scheme
Who may use this agreement
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points · open scheme: new suppliers can join during the term
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
1 May 2025, 16:18 BST
Last source update
4 Sept 2025, 17:47 BST
Award evaluation window
Submission end – 30 Jul 2025
Authority reference
C357509
FTS notice number
2025/S 000-029971
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-050bb9 Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
4 Jul 2025, 13:00 BST
Clarification deadline
27 Jun 2025, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗ Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address

Timeline

1 May 2025 → 1 Oct 2025 · 11 dates
  1. Planning notice published
    1 May 2025, 16:18 BST
  2. Market engagement
    21 May 2025, 23:59 BST

    NHS England is seeking to engage with suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact [email protected] or [email protected] to register your interest in tendering for this framework. Please indicate which products your Company is planning to bring to market in your response.

  3. Next notice expected
    28 May 2025, 23:59 BST
  4. Tender notice published
    4 Jun 2025, 15:34 BST
  5. Clarification questions by
    27 Jun 2025, 13:00 BST
  6. Admission / appointment period endsperiod end, not a bid countdown
    4 Jul 2025, 13:00 BST
  7. Assessment summaries sent
    30 Jul 2025, 00:00 BST
  8. Award decision expected by
    30 Jul 2025, 23:59 BST
  9. Standstill ends
    11 Aug 2025, 23:59 BST
  10. Latest notice published
    4 Sept 2025, 17:47 BST
  11. Contract starts387 days ago
    1 Oct 2025, 00:00 BST

Notice history

10 events · 4 releases on Find a Tender · since 1 May 2025
  1. Preliminary market engagement notice published
    1 May 2025, 16:18 BST
    UK2
  2. Tender notice published
    4 Jun 2025, 15:34 BST
    UK4
  3. Published value updated to £80,909,200
    4 Jun 2025, 15:34 BST
    was £60,945,000
  4. Status changed to active
    4 Jun 2025, 15:34 BST
  5. Procurement method changed
    4 Jun 2025, 15:34 BST
  6. Deadline published: 4 Jul 2025, 13:00 BST
    4 Jun 2025, 15:34 BST
  7. Contract award notice published
    30 Jul 2025, 11:23 BST
    UK6
  8. Status changed to complete
    30 Jul 2025, 11:23 BST
  9. Contract signature expected
    13 Aug 2025, 23:59 BST
    scheduled
  10. Contract details notice published
    4 Sept 2025, 17:47 BST
    UK7
Routine re-releases (4)
  • 2025-05: 1 release · 1 May 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 71 award · see the list ↓
Bids received 157 from SMEs
Named bidders 15published on the award notice
Contracts signed 1latest 18 Aug 2025
Awarded toValueDateStatus
Dr Reddy's Laboratories (UK) Ltd, NOVARTIS PHARMACEUTICALS UK LIMITED, Perennial Pharma Ltd, Pfizer Ltd, Teva UK Ltd, Thornton and Ross Ltd +1 more1 Oct 2025 – 31 Jan 2027 · up to 30 Sept 2029Extensions: option or options to extend (at the discretion of the Authority) up to maximum of 48 months.£52,385,00016 Jul 2025Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
15final-stage tenders70—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY 7&8 Wellington Place, Leeds, Yorkshire & Humber, LS1 4APContact name, email

Framework contractors & participating bidders

15 commercial parties on the notice · 7 awarded
  • ACCORD-UK LTDBidder / tendererGB-COH: 00079585 Whiddon Valley, Devon, South West, EX32 8NS
  • AMAROX LIMITEDBidder / tendererGB-COH: 10997632 Congress House 14 Lyon Road, Harrow, London, HA1 2EN
  • C. S. T. PHARMA LIMITEDBidder / tendererGB-COH: 04212740 Unit 5-7 Tintagel Way, Walsall, West Midlands, WS9 8ER
  • DR REDDY'S LABORATORIES (UK) LIMITEDFramework contractorGB-COH: 01729064 410 Cambridge Science Park Milton Road, Cambridge, East of England, CB4 0PEContact email
  • GLENMARK PHARMACEUTICALS EUROPE LIMITEDBidder / tendererGB-COH: 05040260 2-B Laxmi House, Harrow, London, HA3 0BU
  • KENT PHARMA UK LIMITEDBidder / tendererGB-COH: 11576098 2nd Floor, Connect 38 1 Dover Place, Ashford, South East, TN23 1FB
  • MSN LABORATORIES EUROPE LIMITEDBidder / tendererGB-COH: 10185013 Invision House, Hitchin, East of England, SG4 0TY
  • NOVARTIS PHARMACEUTICALS UK LIMITEDFramework contractorGB-COH: 00119006 2nd Floor, The Westworks Building White City Place, London, London, W12 7FQContact email
  • ORIFARM UK LTDBidder / tendererGB-COH: 10015046 Ground Floor, Suite A2 Breakspear Way, Hemel Hempstead, East of England, HP2 4TZ
  • PERENNIAL PHARMA LTDFramework contractorGB-COH: 11826246 2nd Floor Titan Court, Hatfield, East of England, AL10 9NAContact email
Show 5 more suppliers
  • PFIZER LIMITEDFramework contractorGB-COH: 00526209 Pfizer Limited, Ramsgate Road, Kent, South East, CT13 9NJContact email
  • TEVA UK LIMITEDFramework contractorGB-COH: 00302461 Ridings Point, Castleford, Yorkshire & Humber, WF10 5HXContact email
  • THORNTON & ROSS LIMITEDFramework contractorGB-COH: 00185947 Linthwaite Labs Manchester Road, Huddersfield, Yorkshire & Humber, HD7 5QHContact email
  • VIATRIS UK HEALTHCARE LIMITEDBidder / tendererGB-COH: 09189103 20 Station Close, Potters Bar, East of England, EN6 1TL
  • WOCKHARDT UK LIMITEDFramework contractorGB-COH: 05835570 Ash Road North, Wrexham, Wales, LL13 9UFContact email

Official documents & specifications (6)

Official links; attachments are not copied

Tender pack and attachments

Notices published for this procedure